It’s the sole injectable buprenorphine that gives each weekly and month to month dosing alternatives. BRIXADI is indicated to the treatment of moderate to severe opioid use condition (OUD) in individuals who've initiated treatment with one dose of a transmucosal buprenorphine solution or who are by now becoming taken https://aabyew074hgd9.wikilowdown.com/user